28.02.2013 Views

Handbook of Solvents - George Wypych - ChemTech - Ventech!

Handbook of Solvents - George Wypych - ChemTech - Ventech!

Handbook of Solvents - George Wypych - ChemTech - Ventech!

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

15.2.1 Use <strong>of</strong> breath monitoring 1083<br />

mixed venous blood. These are the prevailing conditions when breath monitoring takes<br />

place after the end <strong>of</strong> the exposure 17 and therefore, samples <strong>of</strong> alveolar air after exposure<br />

should reflect concentrations in mixed venous blood. During exposure, however, alveolar<br />

air should reflect concentrations in arterial blood. Solvent concentrations in arterial and venous<br />

blood diverge even more with physical exertion.<br />

To summarize, the uptake <strong>of</strong> solvent vapors through inhalation will depend on the following<br />

factors: 3<br />

1. Pulmonary ventilation, i.e., the rate at which fresh air (and solvent vapor) enters the<br />

lungs. This is determined by the metabolic rate and therefore depends on physical exertion.<br />

The concentration in alveolar air approaches that in inhaled air when the physical exertion is<br />

great. When exertion is low, the alveolar air concentration approaches the concentration in<br />

mixed venous blood.<br />

2. Diffusion <strong>of</strong> the solvent vapor through the gas-blood interface. According to Fick’s<br />

2nd law, the rate <strong>of</strong> diffusion through the interface depends on the concentration gradient<br />

across the tissue membrane. Therefore, the concentration <strong>of</strong> the vapor leaving the lungs depends<br />

on the amount <strong>of</strong> vapor entering the alveoli, on the solubility in blood (blood/gas partition<br />

coefficient) and on the flow rate <strong>of</strong> the blood through the lungs. For lipophilic<br />

chemicals, such as organic solvents that readily cross cellular membranes, diffusion is not<br />

the rate-limiting factor. 18<br />

3. The solubility <strong>of</strong> the vapor in the blood. The higher the blood/gas partition coefficient,<br />

the more rapidly the vapor will diffuse into the blood, until equilibrium is achieved.<br />

At equilibrium the net diffusion between blood and air ceases, but the concentrations in air<br />

and blood may still be different. A highly soluble vapor will therefore demonstrate a lower<br />

alveolar air concentration relative to the inhaled air concentration during exposure, and a<br />

higher alveolar concentration relative to the inhaled air concentration after exposure.<br />

4. The circulation <strong>of</strong> the blood through the lungs and tissues. This depends on the cardiac<br />

output and therefore, on physical exertion. For a soluble vapor, high exertion moves<br />

blood faster, increasing uptake.<br />

5. The diffusion <strong>of</strong> the vapor through the tissue membranes, which depends on membrane<br />

permeability and is governed by Fick’s law, as discussed in #2 above.<br />

6. The solubility <strong>of</strong> the solvent vapor in the tissue. This reflects the tissue/blood partition<br />

coefficient <strong>of</strong> the solvent vapor and depends largely on the lipid composition <strong>of</strong> the particular<br />

tissue. Lipophilic vapors will exhibit high solubility in tissues with high fat content,<br />

freeing blood <strong>of</strong> vapors and increasing uptake.<br />

Substances that are not well metabolized are eliminated primarily through the lungs 3<br />

and to a lesser extent through the kidneys. During elimination through the lungs the same<br />

physiological principles apply in a reverse sequence.<br />

15.2.1.4 Types <strong>of</strong> exhaled air samples<br />

Samples obtained from even a single breath may contain different concentrations <strong>of</strong> the solvent<br />

vapor <strong>of</strong> interest depending on the way the sample was collected. This is a result <strong>of</strong> the<br />

non-homogeneity <strong>of</strong> the exhaled air discussed previously. Figure 15.2.1.2 depicts a concentration<br />

curve <strong>of</strong> a solvent in exhaled air. When measurement takes place in an environment<br />

free <strong>of</strong> that solvent, the first part <strong>of</strong> the exhalation, corresponding to air in the anatomical<br />

dead space, will be solvent-free (Phase 1). Then the solvent concentration curve rises<br />

sharply reflecting exhalation <strong>of</strong> air from the respiratory zone <strong>of</strong> the lungs (Phase 2). This<br />

phase is followed by a slowly increasing plateau, indicating an alveolar steady state (Phase<br />

3). The level <strong>of</strong> this plateau depends on the preceding ventilatory state <strong>of</strong> the subject, being<br />

higher for a hypoventilating subject and lower for a hyperventilating subject. 6 Sample col-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!